BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 968996)

  • 1. [Oral administration of procainamide for ventricular arrhythmia. Plasma concentrations during use of tablets(Pronestyl) and a slow-release preparation (Porcainamide Durettes)].
    Bliddal J
    Ugeskr Laeger; 1976 Sep; 138(40):2425-33. PubMed ID: 968996
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serum concentrations of procainamide during treatment with ordinary and sustained-release tablets].
    Henningsen P; Laursen HB; Christiansen BD; Moller J
    Ugeskr Laeger; 1976 Sep; 138(40):2433-7. PubMed ID: 968997
    [No Abstract]   [Full Text] [Related]  

  • 3. Procainamide in plasma following administration of sustained-release tablets in acute myocardial infarction.
    Ihlen H; Skomedal T; Stafsnes H; Ditlefsen EM
    Curr Ther Res Clin Exp; 1975 Mar; 17(3):257-62. PubMed ID: 805020
    [No Abstract]   [Full Text] [Related]  

  • 4. Experiences on a sustained-release procainamide preparation.
    Ruosteenoja R; Torsti P; Sothmann A
    Curr Ther Res Clin Exp; 1973 Oct; 15(10):707-12. PubMed ID: 4201315
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma levels of procaine amide after administration of conventional and sustained-release tablets.
    Karlsson E
    Eur J Clin Pharmacol; 1973 Dec; 6(4):245-50. PubMed ID: 4591151
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of a new sustained release procainamide preparation: evaluation with 24-hour Holter monitoring.
    Garcia JR; Godley ML; Freedman RJ
    J La State Med Soc; 1982; 134(1):8-9. PubMed ID: 7086265
    [No Abstract]   [Full Text] [Related]  

  • 7. Conversion from intravenous procainamide to oral sustained release tablets in cardiac patients.
    Kalin ML; Babich MF; Klinke WP; Hui WK
    Can J Cardiol; 1990; 6(1):15-8. PubMed ID: 2310989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained release procainamide in patients with myocardial infarction.
    Birkhead J; Evans T; Mumford P; Martinez E; Jewitt D
    Br Heart J; 1976 Jan; 38(1):77-80. PubMed ID: 1252299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarrhythmic prophylaxis with procainamide in acute myocardial infarction.
    Koch-Weser J; Klein SW; Foo-Canto LL; Kastor JA; DeSanctis RW
    N Engl J Med; 1969 Dec; 281(23):1253-60. PubMed ID: 4900236
    [No Abstract]   [Full Text] [Related]  

  • 10. Procainamide acetylation and disposition in dialysis patients.
    Nattel S; Ogilvie RI; Kreeft J; Sitar DS; Graham DN; Rangno RE; Dufresne LR; Barre PE
    Clin Invest Med; 1979; 2(1):5-11. PubMed ID: 509808
    [No Abstract]   [Full Text] [Related]  

  • 11. The clinical use of procainamide.
    Miller RR; Greenblatt DJ
    Am J Hosp Pharm; 1974 Sep; 31(9):889-91. PubMed ID: 4607729
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical use of sustained-release procainamide in treatment of cardiac arrhythmias.
    Michelson EL; McGeehin FC; Levin BK
    Angiology; 1988 Jul; 39(7 Pt 2):647-54. PubMed ID: 3044199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of plasma levels in evaluation of procainamide dosage.
    Shaw TR; Kumana CR; Royds RB; Padgham CM; Hamer J
    Br Heart J; 1974 Mar; 36(3):265-70. PubMed ID: 4132893
    [No Abstract]   [Full Text] [Related]  

  • 14. Dosage, plasms concentration and antiarrhythmic effect of procainamide in sustained-release tablets.
    Arstila M; Katila M; Sundquist H; Anttila M; Pere E; Tikkanen R
    Acta Med Scand; 1974 Mar; 195(3):217-22. PubMed ID: 4595254
    [No Abstract]   [Full Text] [Related]  

  • 15. Arrhythmia prophylaxis with procaine amide: plasma concentrations in relation to dose.
    Collste P; Karlsson E
    Acta Med Scand; 1973 Nov; 194(5):405-11. PubMed ID: 4757219
    [No Abstract]   [Full Text] [Related]  

  • 16. A new sustained-release tablet formulation of procainamide.
    Fremstad D; Dahl S; Jacobsen S; Lunde PK; Nådland KJ; Marthinsen AA; Waaler T; Landmark KH
    Eur J Clin Pharmacol; 1973 Dec; 6(4):251-5. PubMed ID: 4591152
    [No Abstract]   [Full Text] [Related]  

  • 17. Maintenance therapy with a new retard tablet preparation of procainamide.
    Hansteen V; Landmark KH; Fremstad D; Dahl SG; Jacobsen S; Marthinsen AA; Waaler T; Frislid K; Lunde PK
    Am Heart J; 1976 Jul; 92(1):47-56. PubMed ID: 785987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Arrhythmia prophylaxis with procanamide: inadequate dosage?].
    Collste P; Karlsson E; Norlander B; Sievers J; Sjöqvist F
    Lakartidningen; 1972 Jun; 69():Suppl 2:47-50. PubMed ID: 4645697
    [No Abstract]   [Full Text] [Related]  

  • 19. [Certain problems of antiarrhythmia therapy in myocardial infarct].
    Sivkov II; Kukes VG; Mamedova AD; Rozinov IuI; Maziĭ SA
    Sov Med; 1974 Nov; (11):58-64. PubMed ID: 4439076
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prevention and treatment of drug-induced arrhythmia in acute myocardial infarct].
    Steffen V; Fiehring H
    Z Gesamte Inn Med; 1972 Oct; 27(20):875-81. PubMed ID: 4405247
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.